𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical and biochemical observations in a patient with combined Pompe disease and cblC mutation

✍ Scribed by F. A. Wijburg; D. S. Rosenblatt; G. D. Vos; J. W. E. Oorthuys; L. G. F. M. van't Hek; B. J. H. M. Poorthuis; M. K. Sanders; R. B. H. Schutgens

Publisher
Springer
Year
1992
Tongue
English
Weight
488 KB
Volume
151
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Early-infantile galactosialidosis: Clini
Early-infantile galactosialidosis: Clinical, biochemical, and molecular observations in a new patient
✍ Zammarchi, Enrico; Donati, Maria Alice; Morrone, Amelia; Donzelli, Gian Paolo; Z πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 631 KB

Few patients with the early-infantile form of galactosialidosis have been described to date. Presented here is the first Italian case. Fetal hydrops was detected by ultrasound at week 24 of gestation. At birth, the infant presented with hypotonia, massive edema, a flattened coarse facies, telangiect

A novel mutation of the GAA gene in a Fi
A novel mutation of the GAA gene in a Finnish late-onset pompe disease patient: Clinical phenotype and follow-up with enzyme replacement therapy
✍ Mari P. Korpela; Anders Paetau; Mervi I. LΓΆfberg; Marjut H. Timonen; Antti E. La πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 139 KB

## Abstract Pompe disease is a rare, progressive disease leading to skeletal muscle weakness due to deficiency of the acid α‐glucosidase (GAA) enzyme. Herein we report the first diagnosed Finnish patient with a phenotype compatible with the late‐onset form of Pompe disease. Molecular genetic analys

Two new mild homozygous mutations in Gau
Two new mild homozygous mutations in Gaucher disease patients: Clinical signs and biochemical analyses
✍ Cormand, Bru; Grinberg, Daniel; Gort, Laura; Fiumara, Agata; Barone, Rita; Vilag πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 324 KB

Gaucher disease (GD) is a lysosomal storage disorder resulting from impaired activity of lysosomal ␀-glucocerebrosidase. More than 60 mutations have been described in the GBA gene. They have been classified as lethal, severe, and mild on the basis of the corresponding phenotype. The fact that most G